In this guide
What is testosterone propionate?
Testosterone propionate is a prescription form of testosterone that is injected into a muscle. It is testosterone with the shortest chemical tail used in medicine for men, dissolved in oil. The tail makes it release more slowly than plain testosterone, but only for a day or two, so it has to be injected every few days. Guidelines now prefer other forms, and few countries still sell it on its own. [1], [2], [3]
The name describes the chemistry. "Propionate" is the three-carbon ester (a chemical tail) joined to testosterone. The body snips the tail off to release ordinary testosterone. Because the tail is small, propionate carries more testosterone per milligram than longer esters: 25 mg of testosterone propionate contains 20.9 mg of testosterone, about 84%, compared with about 70% for cypionate. [1], [4], [5]
It is labeled for men with hypogonadism (low testosterone from a medical cause) that has been confirmed by symptoms and blood tests. The Spanish label adds that low testosterone should be confirmed by two separate blood tests, after other causes of the symptoms are ruled out. [1], [6]
| Product | Where | Strength and container | Status (checked September 2026) |
|---|---|---|---|
| Testex | Spain | 25 mg in a 1 mL single-use ampoule | Licensed and marketed; prescription only |
| Testovis | Italy | 100 mg in a 2 mL ampoule | Licensed and marketed; specialist prescription |
| Sustanon 250 | United Kingdom, Australia and Italy, among others checked | 30 mg of propionate plus three longer esters in each 1 mL | Licensed; see the Sustanon 250 guide |
| Compounded propionate | United States | Varies by pharmacy | Not FDA-approved; made from bulk powder |
| Testosterone Propionate Injection USP (StériMax) | Canada | 100 mg/mL vial | Licensed but not marketed since 2017 |
[1], [7], [6], [8], [9], [10], [11], [12], [13], [14]
A little history. Testosterone was first isolated and made in the laboratory in 1935. Propionate was the first injectable form: an official 1937 list of medicines names "Testoviron" (testosterone propionate) from Schering-Kahlbaum in Berlin. The longer-acting enanthate took over from the mid-1950s and remained the main preparation for half a century. Older papers use "depot" names loosely. One gives a "testosterone propionate depot" every 21 days, which is not how plain propionate behaves, so it helps to check which ester and formulation a paper or product actually contains. [15], [16], [17], [18]
People also meet propionate outside medical care, as compounded vials, unlicensed "test prop" or blends with other esters. Those products are not covered by the labels described here, and supraphysiologic (above the natural range) "cycle" doses are not testosterone replacement therapy, or TRT (see TRT vs steroids). [1], [19]

Typical Testosterone Propionate Protocols
| Source | Amount each time | How often | Weekly total | Adjusted by | Source type |
|---|---|---|---|---|---|
| Spanish label · Testex (25 mg/mL) | 25 mg (one 1 mL ampoule) | 2–4 times a week | 50–100 mg | Clinical response; testosterone checked at the start and at regular intervals; no draw time named | Label Deep injection into the buttock, given very slowly |
| Italian label · Testovis (100 mg/2 mL) | 50 mg (1 mL, half an ampoule) | Twice a week, for at least 2 months | 100 mg | Individual adjustment to keep testosterone normal; no draw time named | Label Label dose for adult hypogenitalism (eunuchoidism); the unused half of the ampoule is thrown away |
| European Association of Urology (EAU) 2026 | 50 mg | Every 2–3 days | About 117–175 mg (averaged) | Not stated for propionate | Guideline The guideline calls this injection frequency a major limitation of propionate |
Every label and guideline gives propionate as an injection into a muscle every 2 to 4 days, because one dose keeps testosterone raised for only about 1 to 2 days. The two labels' weekly totals are 50 to 100 mg. [1], [6], [3], [2]
- Titration Adjusting the dose in steps
- The Spanish label lets the patient's clinical response set both the dose and the number of injections. The Italian label asks for the dose to be adjusted for each man to keep testosterone in the normal range. Both ask for testosterone to be measured at the start and at regular intervals. Neither label, and no guideline, says when after a propionate injection blood should be drawn: the guideline rules about mid-cycle or trough draws were written for enanthate and cypionate. For propionate, draw timing is not established. [1], [6], [20], [21] See why timing matters so much.
- Breaks and cycles
- Not applicable. Testosterone replacement is continuous treatment, and no guideline describes planned breaks. The Italian label's advice to alternate 4-week courses with equal breaks applies only to doses above replacement, not to treating hypogonadism. Stopping is a separate decision (what happens when you stop). [6]
Read the units. Doses are written in milligrams (mg) of testosterone propionate, but you draw a volume, and the volume depends on the strength. Spain's 25 mg dose is the whole 1 mL ampoule. Italy's 50 mg dose is 1 mL, half of the 2 mL ampoule. At 100 mg/mL, the highest strength of the discontinued US vials and the strength of the Canadian vial, 50 mg is 0.5 mL, which is 50 units on a U-100 insulin syringe. The amount each time and the weekly total are different numbers: 25 mg 4 times a week is 100 mg a week. Milligrams also differ between esters: a milligram of propionate carries more testosterone than a milligram of cypionate (see why). Doserly's TRT dose calculator does the arithmetic for any strength and schedule. [1], [6], [22], [14]
These are labeled and guideline doses; prescribers adjust them using blood tests and symptoms. The ranges above are for adult men. For women, see testosterone therapy for women, which uses different products and far smaller doses.
Cautions for every schedule above. The Spanish label rules propionate out in women. In men, it rules it out with prostate cancer or a PSA above 4 ng/mL, an enlarged prostate, past or present liver tumors, male breast cancer, high calcium in the blood or urine, or a hematocrit above 50%. It must go into a muscle slowly and never into a vein. It switches off sperm production (fertility), and hematocrit, blood pressure and PSA (prostate-specific antigen, a prostate blood test) need checking (monitoring). [1]
Where these numbers come from
The Spanish row comes from the Testex product information (revised February 2026) and the Italian row from the Testovis product information (document dated June 13, 2017). Both products are listed as authorised and marketed in their national registers (checked September 2026). The Italian label names male hypogonadism as its first use but gives no dose for it. The 50 mg twice-a-week dose shown is the one it gives for adult hypogenitalism (eunuchoidism), the closest listed condition. It also lists older uses, such as depression and several women's conditions, that this guide does not present. [1], [7], [6], [8]
The guideline row comes from the text of the European Association of Urology guideline (2026 edition). Its weekly total is a simple average of 50 mg every 2 or every 3 days; the guideline does not state it. [3]
Not used for any row: 25 mg 3 times a week from a 1989 study in men with Klinefelter syndrome, because its abstract reports results for three testosterone preparations together (see the study table); the value of 100 mg every 2 days in the summary tables of the European and Italian guidelines, which is about 350 mg a week and conflicts with the European guideline's own text (see the disagreement); a US label schedule, because no current US propionate label exists and the often-quoted US dosing could not be found in any label text; daily or every-other-day subcutaneous injections, which appear only in community reports (community); and any bodybuilding or "cycle" dose. [23], [3], [22], [24]
What is testosterone propionate commonly used for?
Its licensed use is replacing testosterone in men with hypogonadism: either primary hypogonadism, where the testicles fail, or hypogonadotropic hypogonadism, where the brain and pituitary do not send enough signal. The Spanish label says it is not a treatment for infertility, or for sexual problems in men without a proven testosterone deficiency. [1], [6]
What does testosterone replacement improve?
The benefits are those of testosterone itself, whatever the ester. In trials, testosterone for low testosterone mainly improves sexual desire and activity. In the TRAVERSE trial's men with low libido, sexual activity rose by about half an act a day more than on placebo, but erections did not improve. In the Testosterone Trials of men 65 and older, a year of gel improved sexual function a little but not energy or walking in the physical function trial. No trial has measured these outcomes with propionate itself. [25], [26] See the results timeline guide and TRT: the definitive guide.
How long does testosterone propionate take to work?
Blood levels rise within hours. In healthy men given 25 mg, the ester was already in the blood 3 hours later and stayed there for about a day and a half. Symptoms change more slowly and on the same timeline as other forms of testosterone. A widely cited review found sexual interest improving after about 3 weeks, erections over up to 6 months and body composition over 12 to 16 weeks. [27], [28]
Why is propionate rarely used for TRT today?
Mainly because of how often it has to be injected. The European urology guideline says propionate needs "multiple fractionated doses (usually 50mg, every two to three days), thus representing a major limitation for its use." The European urology guideline and the European Academy of Andrology both say older injections such as propionate cause wide swings in testosterone. They add that these may bring more red-cell rises. The Italian andrology guideline also notes wider swings with short-acting injections and prefers gels or long-acting injections. The British Society for Sexual Medicine lists propionate only as one of the four esters in Sustanon 250. [3], [23], [29], [30]
Availability adds to it. In the United States and Canada no propionate medicine is marketed, so a prescriber who wants it must use a compounding pharmacy (in the US) or look abroad. [22], [13], [14]
Where do testosterone propionate protocols differ?
The disagreements are about how much, how often, where to inject and when to draw blood. Most come from how little propionate-specific research exists.
Is the dose from a label or a guideline?
The two labels agree on 50 to 100 mg a week; the European guideline's text implies more, and its summary table far more. The Spanish label gives 50 to 100 mg a week and the Italian label 100 mg a week. The European urology guideline's text says usually 50 mg every 2 to 3 days, which averages about 117 to 175 mg a week. Its summary table, like the Italian andrology guideline's table, lists 100 mg every 2 days, about 350 mg a week. That is 3.5 to 7 times the labels' weekly totals and 2 to 3 times the guideline's own text. This guide shows the text value in the protocol table and leaves the table value out. [1], [6], [3], [23]
How often should it be injected?
The labels say 2 to 4 times a week and the guideline every 2 to 3 days, all because one dose wears off within 1 to 2 days. Online, many men describe daily or every-other-day injections of 10 to 25 mg, often subcutaneous (into the fat). No guideline or peer-reviewed practice source gives a complete schedule for those patterns, and no study has compared daily with every-2-to-3-day propionate. [1], [3], [2] What people report is in the community section.
Into muscle or into the fat?
Both current propionate labels say into a muscle only: Spain's specifies deep in the buttock, injected very slowly. No human study has measured propionate levels, comfort or safety after subcutaneous injection (into the fatty layer under the skin), and no registered trial is testing it. [1], [31]
The evidence for weekly subcutaneous testosterone comes from enanthate and cypionate. The UK Society for Endocrinology accepts that route for those two esters, but that does not show how a short, fast-releasing ester behaves as a subcutaneous injection. Injection technique is covered in how to inject testosterone. [21]

When should blood be drawn?
No label or guideline says, and on propionate the timing changes the result more than on any other testosterone injection. Guidelines disagree even for longer esters: some judge injections by a level midway between doses, others by the trough (the lowest level, just before the next dose). With propionate, both points fall within a day or two of the injection. So a level drawn a few hours after a dose and one drawn just before the next can describe the same schedule very differently. [20], [21], [2]
| Guideline | When to draw on injections | Written for |
|---|---|---|
| International Consultation on Sexual Medicine 2024 | Mid-cycle | Short-acting injections (enanthate, cypionate) |
| Society for Endocrinology (UK) 2022 | Trough, before the next injection | Enanthate, cypionate and Sustanon |
| Propionate labels (Spain, Italy) | Not stated; testosterone at the start and at regular intervals | Propionate |
Whatever timing a prescriber uses, recording the date and time of the last injection with every result makes results comparable. See TRT blood work for the full picture.
Is propionate "short-acting"?
It depends on who is talking. The European urology guideline calls propionate, cypionate and enanthate all "short-term" formulations, and the Italian guideline calls propionate "very short-acting." A 2023 urology review instead calls every injection into a muscle "long-acting" and keeps "short-acting" for nasal, oral and skin products. That matters because statements that "short-acting testosterone" affects fertility less are about nasal, oral and skin products, not propionate injections. [3], [23], [32]
What happens when you stop testosterone propionate?
The drug is gone within days; your own hormone production takes much longer to return.
- The last injection. After a single 25 or 50 mg dose, levels fell back within 1 to 2 days, and the pituitary's signal to the testicles, luteinizing hormone (LH), stayed suppressed only while testosterone stayed raised. [2]
- Your own testosterone. After weeks or years of treatment, recovery of LH, FSH (follicle-stimulating hormone) and your own testosterone depends on the cause of low testosterone and how long treatment lasted. No study shows that recovery is faster after propionate than after longer esters, and in men with a lasting cause of hypogonadism, low testosterone is expected to return. [2], [21]
- Sperm. In contraceptive trials of healthy men given testosterone alone or with a progestin, sperm counts returned to 20 million per mL in 67% within 6 months, 90% within 12 months and 100% within 24 months. That pooled analysis linked shorter-acting testosterone preparations with faster recovery, though not more complete recovery; its abstract does not name propionate. The Spanish label describes the effect on sperm production as reversible. [33], [1]
See stopping TRT for the full picture, including fertility recovery and what men describe.
How does testosterone propionate compare with other forms?
It is the shortest-acting injectable ester used for men. Compared with cypionate or enanthate, one dose lasts days rather than a week or more, so it needs several injections a week, and levels rise and fall within each few days. [2], [3]
How long does testosterone propionate last in the body?
About 1 to 2 days per dose. In a 1976 study of healthy men and men with hypogonadism, testosterone stayed above the lower physiological limit for 1 day after 25 mg of propionate and 2 days after 50 mg. After 250 mg of enanthate it stayed above that limit for 14 days. LH was suppressed for the same periods. [2]
Two small Japanese studies used a tracer-tagged (deuterium-labelled) dose, so testosterone from the injection could be told apart from the body's own. In healthy men given 25 mg, testosterone from the dose stayed above the normal level for 48 hours. In three men with hypogonadotropic hypogonadism, one dose (the amount is not given in the abstract) kept it above 400 ng/dL (about 14 nmol/L) for 48 hours. [27], [34]
One older study found a longer effect. In 28 men over 60, one 100 mg dose of a product labelled testosterone propionate kept testosterone above their starting levels through day 7, and levels were back to baseline by day 15. Blood was drawn only on days 2, 4, 7 and 15, and the abstract does not describe the formulation; its title calls it depot testosterone. The dose was 2 to 4 times the 25 and 50 mg doses above, and it measured a rise above each man's own starting level rather than above the normal limit. This guide follows the 1 to 2 day figure, which the other studies and the labels' dosing agree on. [35]
Its half-life is quoted in different ways. The European and Italian guideline tables list 20 hours without naming the study behind it, and the Italian label claims one injection works for about 4 weeks, which the human measurements above contradict. Testosterone itself has a half-life of only 10 to 100 minutes once it reaches the blood; the Spanish label explains that an ester's absorption rate depends on the size of its tail, and propionate's is the smallest in use. So the ester, not testosterone, sets the dosing interval. [3], [23], [6], [1]

How long one dose lasts, and how often it is given
Days above the lower normal limit after one injection
Nieschlag 1976: healthy men and men with hypogonadism; group sizes not given.
- Propionate 25 mg
- About 1 day
- Propionate 50 mg
- About 2 days
- Enanthate 250 mg
- About 14 days
- Separate study (Fujioka 1986)
- In healthy men given one tracer-tagged 25 mg dose, testosterone from the dose stayed above the normal level for 48 hours.
Labeled schedules across one week
Each dot is one injection on days 1 to 7. Days are illustrative; labels give how often, not which days. Schedules only, not blood levels.
- Spain label: 25 mg, 2 times a week
- 50 mg a week
- Spain label: 25 mg, 4 times a week
- 100 mg a week
- Italy label: 50 mg, twice a week
- 100 mg a week
- European urology guideline (text): 50 mg every 2 to 3 days
- About 117–175 mg a week on average. Filled dots: every 2 days; hollow dots: every 3 days.
One dose wears off within 1 to 2 days, so every labeled schedule gives propionate at least twice a week.
What do the peaks and troughs look like?
No openly readable study charts levels across repeated propionate doses. Guidelines agree on the pattern: the older injectable esters, propionate included, produce wide swings in testosterone that patients often find unpleasant, and possibly more red-cell rises. One older study in men with alcohol-related liver cirrhosis found fairly steady levels after 4 days of every-other-day propionate. No study has compared daily with every-2-to-3-day injections. [3], [29], [23], [36]
Doserly's testosterone level visualizer can draw a rough, relative propionate curve for any schedule. It uses the guideline's 20-hour half-life and an assumed time to peak, so treat it as an illustration, not a prediction.
Is propionate stronger than cypionate mg for mg?
Yes, by about a fifth, because its tail is lighter. Testosterone makes up about 84% of testosterone propionate by weight, compared with about 72% of enanthate, 70% of cypionate and 63% of undecanoate. So 100 mg of propionate carries about 84 mg of testosterone, and 100 mg of cypionate about 70 mg. [4], [1]

How much testosterone is in each ester
TestosteroneEster tail (removed in the body)
- 100 mg testosterone propionate
- About 84 mg testosterone
- 100 mg testosterone enanthate
- About 72 mg testosterone
- 100 mg testosterone cypionate
- About 70 mg testosterone
- 100 mg testosterone undecanoate
- About 63 mg testosterone
| Ester | Molecular weight | Testosterone share |
|---|---|---|
| Propionate | 344.5 g/mol | 83.7% |
| Enanthate | 400.6 g/mol | 72.0% |
| Cypionate | 412.6 g/mol | 69.9% |
| Undecanoate | 456.7 g/mol | 63.1% |
| Testosterone itself | 288.4 g/mol | 100% |
The Spanish label gives the same ratio: 25 mg of testosterone propionate contains 20.9 mg of testosterone. A higher share does not make one ester better; it means milligrams cannot be swapped one for one.
That is why switching between esters is a prescriber's decision rather than a straight swap. The US cypionate label warns that cypionate "should not be used interchangeably with testosterone propionate because of differences in duration of action." A switch changes the amount of testosterone, how often it is injected and when blood should be drawn. [5]
Is testosterone propionate the same as Sustanon 250?
No. Sustanon 250 contains propionate as one of four esters: 30 mg of propionate, 60 mg of phenylpropionate, 60 mg of isocaproate and 100 mg of decanoate in each 1 mL. The propionate gives a fast start, and the longer esters let one injection usually last 3 weeks. Levels peak at about 70 nmol/L (about 2,020 ng/dL) 24 to 48 hours after the injection and return to the lower normal limit in about 21 days. See the Sustanon 250 guide. [9], [11]
What about cypionate-propionate blends?
Blends are made by compounding pharmacies, not sold as approved medicines in the United States. An FDA warning letter to one outsourcing facility records a compounded "Testosterone cypionate/ Testosterone propionate 200mg/10mg Injection," and mixed enanthate and propionate products have been used as TRT in other countries. No study has tested a blend's levels, benefits or safety. [19], [37]
What is in the ampoule?
Testosterone propionate dissolved in oil. The Spanish product uses ethyl oleate and olive oil; the Italian product uses sesame oil, and its label warns that sesame oil can rarely cause severe allergic reactions. The US pharmacopeia standard describes the injection as a sterile solution in "a suitable vegetable oil," so compounded products can use different oils. [1], [6], [38]
Does testosterone propionate hurt more than other injections?
No study has compared injection pain between esters, so the reputation rests on personal accounts. The Italian label lists a firm swelling at the injection site and boils with injections into muscle, and the Spanish label lists no injection-site reaction. A general caution applies to all oil injections: a case report describes oil-filled lumps (oleomas) forming years after unsupervised testosterone-in-oil injections, with the ester not identified. [6], [1], [39] What people report is in the community section.
Can oil injections cause a cough?
Rarely. The Spanish label warns that oil can reach the lungs as tiny droplets (pulmonary oil microembolism), causing cough, shortness of breath, sweating, chest pain, dizziness, tingling or fainting during or just after the injection. These reactions are reversible, and the label asks for the patient to be watched during and just after each injection. [1]
How should testosterone propionate be stored?
Neither label asks for refrigeration. Each product's leaflet is the final word. [1], [6]
| Product | Storage | After opening |
|---|---|---|
| Testex (Spain) | No special storage conditions | Single use: use immediately after opening and discard the rest |
| Testovis (Italy) | Keep in the original pack to protect from light | Discard any part of the ampoule not used |
Compounded vials come with the pharmacy's own storage and discard dates. For carrying ampoules or vials on a trip, see traveling with testosterone. This guide does not teach injection technique; the Academy note below covers the practical basics, and how to inject testosterone covers sites and needles.
What does testosterone propionate do to fertility, estrogen and red blood cells?
These three effects come with every form of testosterone; each has its own hub guide. Here is what is specific to propionate.
Fertility. Propionate switches off LH for as long as its levels are raised, and the labels warn that testosterone reduces sperm production. No human study has measured propionate's effect on sperm. The claim that it "spares" fertility rests on one mouse study, in which normal (not hypogonadal) mice were given propionate into the abdomen three times a week and reached lower testosterone levels than mice given pellets (122 vs 286 ng/dL). The US male infertility guideline advises against testosterone for men who want children now or in the future, and the European urology guideline advises against it for men wishing to become fathers. See TRT and fertility. [2], [1], [31], [40], [41], [3]
Estrogen. Some testosterone is converted into estradiol, and the Spanish label lists breast enlargement (gynecomastia) among possible effects. No study shows that propionate, or injecting it more often, lowers estradiol. No guideline sets a routine estradiol target: the AUA measures it mainly when breast symptoms appear. See estrogen on TRT. [1], [42]
Red blood cells. The Spanish label lists a rise in red blood cells (polycythemia), hematocrit and hemoglobin as common, affecting between 1 in 100 and 1 in 10 people, and rules propionate out when hematocrit is above 50%. European guidelines link the swings of older injections with possibly more red-cell rises. No trial has tested whether small, frequent propionate doses raise hematocrit less. The nearest evidence is observational: hematocrit passed 54% in 1 of 102 men on 100 mg weekly and 4 of 51 on 200 mg every 2 weeks, with the ester not stated. See hematocrit on TRT. [1], [29], [3], [43]
What do we actually know about testosterone propionate in people?
That it raises testosterone for a day or two after each injection is well measured. Almost everything else about it, from long-term safety to fertility, comes from studies of other forms of testosterone.

Which studies used propionate itself?
| Study | Who and what | What it found | What it cannot show |
|---|---|---|---|
| Nieschlag 1976 (human report) | Healthy men and men with hypogonadism; single doses of 25 or 50 mg of propionate and 250 mg of enanthate | Testosterone above the lower normal limit for 1 day (25 mg), 2 days (50 mg) and 14 days (enanthate); LH suppressed for the same periods | Repeated dosing; abstract only, group sizes not given [2] |
| Fujioka 1986 (human report) | Healthy men; one tracer-tagged (deuterium-labelled) 25 mg dose into muscle | The ester stayed in the blood from 3 to 36 hours; testosterone from the dose stayed above the normal level for 48 hours | Repeated dosing; no half-life in the abstract [27] |
| Fujioka 1989 (human report) | 3 men with hypogonadotropic hypogonadism; one tracer-tagged dose | Testosterone above 400 ng/dL (about 14 nmol/L) for 48 hours | Only 3 men; dose not given in the abstract [34] |
| Ruiz 1980 (human report) | 28 men over 60; one 100 mg dose of a product labelled testosterone propionate | Testosterone above starting levels through day 7; back to baseline by day 15 | Formulation not described in the abstract; blood drawn only on days 2, 4, 7 and 15 [35] |
| Shi 1989 (human report) | 17 men with Klinefelter syndrome and 6 healthy men; propionate 25 mg 3 times a week was one of three injectable preparations compared | Testosterone rose; high LH fell to normal in about a month and FSH over 3 to 6 months | 3 injectable preparations compared; results not reported per preparation; abstract only [44] |
| Gluud 1981 (human report) | 24 men with alcohol-related cirrhosis across three regimens (propionate group size not given); propionate every other day | Fairly steady levels after 4 days | Men with liver disease; units in the abstract look wrong [36] |
| Chu 2020 (animal study) | Normal mice; propionate into the abdomen 3 times a week vs pellets for 3 months | LH and fertility better preserved than with pellets, at lower testosterone levels | Anything about men; the groups had unequal exposure [40] |
A search of ClinicalTrials.gov found no registered trial of propionate for low testosterone. [31]
What did the large trials of other forms find?
- TRAVERSE (about 5,200 men, daily gel, used for 21.7 months on average; about 61% stopped early): heart attack, stroke or heart death occurred in 7.0% vs 7.3% on placebo, which met the trial's safety margin. Heart-rhythm, kidney, clot and fracture events were more common (full results). In substudies it did not stop prediabetes turning into diabetes, and it did not treat low-grade persistent depression. [45], [46], [47], [48]
- Testosterone Trials (790 men aged 65 or older, gel for 1 year): small gains in sexual function and mood; no gain in energy or walking in the physical function trial. [26]
Whether those results transfer to propionate is not known. Its fast peaks and troughs are unlike a daily gel, and European guidelines flag possibly more red-cell rises with older injections. [3], [29]
How does testosterone propionate work?
Once injected, the oil forms a small depot in the muscle. The ester moves out of the oil into the blood, where it is broken down to free testosterone. Propionate's small tail lets it leave the depot quickly, so the depot is used up within a day or two. [1], [49]
Testosterone then acts like the body's own hormone. In many tissues it works after being converted to dihydrotestosterone (DHT), and some is converted to estradiol. In the blood, about 98% is bound to proteins such as sex hormone-binding globulin and albumin, and only about 2% is free. [1]
Why it switches off your own production. The brain senses testosterone from any source. When levels rise, the pituitary lowers its LH signal to the testicles; after propionate, LH stayed suppressed for as long as testosterone stayed raised. Without LH the testicles make little testosterone, and sperm production falls. [2], [1]
Why it raises red blood cells. Testosterone acts on the bone marrow, and the Spanish label lists blood formation among the processes it drives. The size of the rise with propionate has not been measured. [1]
What are the risks and unanswered questions?
Is testosterone propionate safe?
For men with a confirmed diagnosis and regular monitoring, it carries the known risks of testosterone: more red blood cells, blood clots, higher blood pressure, fluid retention, breast enlargement, prostate effects and loss of fertility. What is uncertain is everything specific to propionate: no modern trial has measured its long-term safety, and the largest safety trial used a gel. [1], [45]
What side effects do the labels list?
The Spanish label, the most recent propionate label, lists these by how often they occur:
- Common (between 1 in 100 and 1 in 10): a rise in red blood cells, hematocrit and hemoglobin; weight gain; and worsening high blood pressure.
- Uncommon (between 1 in 1,000 and 1 in 100): allergic reactions, higher triglycerides and cholesterol, more appetite, headache, nervousness, aggression, irritability, depression, hot flushes, sleep apnea, diarrhea, nausea and changes in liver tests.
- Rare (between 1 in 10,000 and 1 in 1,000): pulmonary oil microembolism.
- Also listed: acne, a rise in PSA and prostate enlargement; oily skin, hair loss and itching; muscle cramps; urinary problems; changes in libido; more frequent or prolonged erections (priapism); breast enlargement and tenderness; smaller testicles at high doses; and fluid and salt retention.
The Italian label also lists hives, a firm swelling at the injection site and boils with injections into muscle. The Spanish label adds that irritability, nervousness and weight gain can be signs of too much testosterone that call for a lower dose. [6], [1]
Does testosterone propionate affect the heart?
No heart-outcome trial has used propionate. The best evidence on testosterone and the heart comes from TRAVERSE, a randomized trial of about 5,200 men aged 45 to 80 with heart disease or high heart risk, given daily testosterone gel or a placebo gel. Among the 2,596 men who used testosterone gel and the 2,602 who used placebo gel, it found:
- Heart attack, stroke or heart death: 182 men (7.0%) on testosterone vs 190 (7.3%) on placebo; hazard ratio 0.96, with a 95% confidence interval of 0.78 to 1.17. The top of that range stayed below the trial's safety margin of 1.5, so a large rise in risk was ruled out. [45]
- Heart rhythm: atrial fibrillation 3.5% vs 2.4%; nonfatal rhythm problems needing treatment 5.2% vs 3.3%. [46]
- Kidneys: acute kidney injury 2.3% vs 1.5%. [46]
- Clots: venous clots 1.7% vs 1.2%, including pulmonary embolism 0.9% vs 0.5%. [46]
- Fractures: 91 of 2,601 men (3.50%) vs 64 of 2,603 (2.46%), counting every randomized man. [50]
- Blood pressure: systolic pressure rose 1.0 mm Hg on testosterone and fell 0.5 mm Hg on placebo by 36 months. [46]

TRAVERSE: absolute results
Testosterone gel (2,596 men)Placebo gel (2,602 men)
- Heart attack, stroke or heart death
- Testosterone 7.0% vs placebo 7.3% (182 vs 190 men; hazard ratio 0.96, 95% CI 0.78–1.17; met the 1.5 safety margin)
- Nonfatal rhythm problems needing treatment
- Testosterone 5.2% vs placebo 3.3%
- Atrial fibrillation
- Testosterone 3.5% vs placebo 2.4%
- Clinical fracture
- Testosterone 3.5% vs placebo 2.5% (91 of 2,601 vs 64 of 2,603 in the full analysis set)
- Acute kidney injury
- Testosterone 2.3% vs placebo 1.5%
- Venous clots (all)
- Testosterone 1.7% vs placebo 1.2%
- Pulmonary embolism
- Testosterone 0.9% vs placebo 0.5%
About 5,200 men aged 45–80 at high heart risk; daily gel; mean treatment 21.7 months; about 61% stopped their study gel. Not a trial of injections.
Its limits matter for propionate. TRAVERSE tested only a gel, the average man used it for 21.7 months, about 61% stopped their study gel early, and it enrolled men at high heart risk. It did not test the sharp peaks of short injections. [45], [46]
The Spanish label adds that in men with severe heart, liver or kidney disease, testosterone can cause serious fluid retention with or without heart failure, in which case treatment must stop at once. [1] See TRT and heart health for the full picture.
Could testosterone propionate affect the prostate?
Testosterone can enlarge the prostate and raise PSA slightly. The Spanish label rules propionate out with prostate cancer or a PSA above 4 ng/mL and with an enlarged prostate, and asks for yearly prostate checks. TRAVERSE excluded men with a PSA above 3.0 ng/mL. In the trial, PSA rose about 0.15 ng/mL more than on placebo at 12 months. High-grade prostate cancer occurred in 5 of 2,596 men on testosterone (0.19%) vs 3 of 2,602 on placebo (0.12%), a difference that was not significant. [1], [51] See TRT and the prostate.
Is testosterone propionate legal? Is it FDA approved?
Checked September 2026. Rules differ by country and change often.
United States. No FDA-approved testosterone propionate product is marketed. The key points:
- Approval history. All 9 propionate applications in FDA's database are listed as discontinued, and the brand-name Perandren Propionate Injection was withdrawn at its maker's request in 1986. DailyMed holds no current human propionate label. [22], [52], [24]
- Controlled substance. Testosterone and its esters are Schedule III anabolic steroids, and testosterone is named in the law itself. [53], [54]
- Compounding. Pharmacies may compound from bulk ingredients that meet a US pharmacopeia standard, and one exists for propionate. Every current US drug listing for propionate is Schedule III bulk powder, several marked for prescription compounding. For larger outsourcing facilities, FDA still lists propionate as under evaluation. Compounded products are not FDA-approved, and the AUA advises commercially made testosterone over compounded products when possible. [55], [56], [13], [57], [42]
- Label changes. FDA's February 2025 class-wide label changes and its June 18, 2026 requests (still requests, not yet in any label) apply to approved testosterone products; no current propionate label exists for them to change. [58], [59]
- Telehealth. Temporary rules let clinicians prescribe controlled medicines such as testosterone without an in-person visit through December 31, 2026; a permanent Drug Enforcement Administration (DEA) special-registration rule is still under review. [60], [61]
Canada. Testosterone is a Schedule IV controlled substance. No human propionate product is marketed: StériMax's 100 mg/mL injection has been dormant since August 3, 2017, Taro's product was cancelled in 2001 and Malogen in Oil in 1999. [62], [14], [63]
United Kingdom. Testosterone is a Class C controlled drug (Schedule 4 Part II), prescription-only. The only UK medicine with current product information that contains propionate is Sustanon 250. [64], [10]
Australia. Testosterone is a Schedule 4 (prescription-only) medicine with extra controls on possession. Among current product information documents, propionate appears only in Sustanon 250. [65], [66]
European Union. Rules and products are national. Spain markets Testex as a prescription medicine, and Italy markets Testovis, fully reimbursed on a restricted specialist prescription; other member states were not checked for this guide. [7], [8] See TRT in Europe.
A research use only label on a vial does not make it legal, tested or the same as a licensed product.
Is testosterone propionate banned in sport? Does it show up on a drug test?
Yes. Testosterone and its esters are on the World Anti-Doping Agency (WADA) Prohibited List in class S1, banned in and out of competition, and the 2027 list keeps that from January 1, 2027. The Spanish label warns that it can cause a positive doping test, and Italy's medicines register flags Testovis as banned in and out of competition. Athletes with a medical need can apply for a therapeutic use exemption, which WADA grants only when low testosterone has an organic cause, such as a testicular or pituitary disorder, not for age, obesity or earlier steroid use. [67], [68], [1], [8], [69]
No source gives a detection window for propionate, so there is no reliable clearance time to plan around.
Who should be especially cautious?
- Men who want children now or soon. Testosterone suppresses sperm production; guidelines advise against it for men trying to conceive. [41], [3]
- Men with prostate or breast cancer, an enlarged prostate or a PSA above 4 ng/mL. Ruled out on the Spanish label. [1]
- High hematocrit. The Spanish label rules it out above 50%. [1]
- High calcium. The Spanish label rules it out with high calcium in the blood or urine (hypercalcemia or hypercalciuria). In men with cancer that has spread to bone, it asks for regular calcium checks. [1]
- Heart, kidney or liver disease, or high blood pressure. Fluid retention and blood-pressure rises can worsen these. [1]
- Epilepsy, migraine or diabetes. The Spanish label asks for caution because fluid retention can worsen epilepsy and migraine, and testosterone can lower blood sugar. [1]
- A history of clots, a clotting disorder or sleep apnea. The Spanish label cites reports of clots in the legs, lungs and eyes during testosterone treatment, and of worsening sleep apnea, especially with obesity or lung disease. Leg pain or swelling, or sudden shortness of breath, need urgent assessment. [1]
- Men over 65. Both labels note limited experience in this age group. [1], [6]
- Women and children. It is contraindicated in women and in pregnancy, and the Spanish label is for men over 18 only; these guides are for men. [1]
- Drug-tested athletes. Banned at all times. [67]
- People taking other medicines; see the next question.
Can testosterone propionate be taken with other medicines?
No interaction studies have been done with propionate itself. The Spanish label lists these:
- Blood thinners (oral anticoagulants such as warfarin). Testosterone can increase their effect; the label advises closer checks of blood-clotting tests (INR and prothrombin time), especially when starting and stopping testosterone.
- Insulin and diabetes medicines. Testosterone can improve glucose tolerance and lower the need for them.
- SGLT-2 inhibitors (a type of diabetes medicine). Taking them together has been linked with a higher risk of too many red blood cells; the label advises checking hematocrit and hemoglobin.
- Corticosteroids or ACTH. Together they can increase fluid retention.
- Ciclosporin, levothyroxine and paclitaxel. Testosterone can increase their effects or exposure.
- Enzyme-inducing medicines such as carbamazepine, phenytoin and phenobarbital, which can change testosterone levels.
Testosterone can also lower thyroxine-binding globulin, which changes total thyroid hormone results without changing thyroid function. Bring a full list of everything you take, including supplements, to a pharmacist or doctor. [1]
Is testosterone propionate still available, and what does it cost?
Checked September 2026.
It depends on the country. It is marketed in Spain and Italy, where Italy's national health service fully reimburses it on a specialist prescription. In the UK and Australia it is available only inside Sustanon 250. In the United States and Canada no propionate medicine is marketed, and in the United States it comes only from compounding pharmacies, at prices set by each pharmacy; no official price exists. [7], [8], [10], [66], [22], [14]
No longer sold: US and Canadian propionate injections
- United States. The brand-name Perandren Propionate Injection (Ciba-Geigy, application NDA 7-029) was withdrawn as no longer marketed, effective November 10, 1986. Generic propionate injections of 25, 50 and 100 mg/mL from several makers are all listed as discontinued. [52], [22]
- Canada. StériMax's 100 mg/mL injection has been dormant (not marketed) since August 3, 2017. Taro's product was cancelled on August 21, 2001, and Malogen in Oil on April 14, 1999. [14], [63]
- A trace in a current label. The US Testopel pellet label still sets its dose in propionate terms: two 75 mg pellets for each 25 mg of testosterone propionate needed each week. [70]
What should be monitored while using testosterone propionate?
The propionate labels give their own schedules, and guidelines add the numbers. Use this summary to prepare questions for your prescriber; it is not a personal testing plan. [1], [6]
| Why it matters | What labels and guidelines say | Tracking category |
|---|---|---|
| Testosterone level | Both labels: at the start and at regular intervals, aiming for the normal range. No source gives a draw time after a propionate injection (timing) | Blood work; Libido; Energy Levels |
| Hematocrit and hemoglobin | Italian label: before treatment, every 3 months for the first year, then yearly. Spanish label: not to start above 50%. Endocrine Society: stop if above 54% until it falls. AUA: intervene at 54% or higher. VA: adjust above 51%, stop above 54%. Society for Endocrinology: adjust above 50% | Blood work |
| PSA and prostate | Spanish label: prostate and breast checks at least yearly; for men over 40 or at risk, every 3 months in the first year, then twice a year. Italian label: rectal exam and PSA before treatment, every 3 months for the first year, then yearly. Endocrine Society: urology referral if PSA rises by more than 1.4 ng/mL in the first 12 months or exceeds 4.0 ng/mL | Blood work; Urinary Symptoms |
| Liver tests and lipids | Both labels: periodically during long-term treatment | Blood work |
| Blood pressure | Spanish label: use with caution in high blood pressure | Blood Pressure |
| Breasts, mood, sleep | Labels list breast enlargement, irritability, depression and sleep apnea | Hormonal Symptoms; Mood & Wellbeing; Sleep Quality |
| Fertility | Semen analysis only if fertility matters; testosterone suppresses sperm production | Other (semen result) |
[6], [1], [71], [42], [72], [21]
The European urology guideline acts on hematocrit above 54%, and the Canadian Urological Association uses 55%. Apart from the Spanish label's 50% starting limit, numeric limits come from guidelines; US labels say only to stop if hematocrit is "elevated." [3], [73], [74] See TRT blood work and hematocrit on TRT.
Write down the timing. For every testosterone result, note the date and hour of the last injection and the dose. On propionate, a result without its timing is close to impossible to interpret.
What do people in public communities report?
Most men describing propionate online were not using a licensed propionate medicine. Many managed their own treatment with products bought online or from unlicensed labs; a few used pharmacy-compounded vials or European ampoules. The accounts below come from public Reddit threads posted since September 2025 and are described without identifying anyone. Threads about steroid cycles, a large share of propionate discussion, are left out.
Why do people look for propionate, and can they get it?
Most hope it will fix something a longer ester did not, usually a low sex drive, a "flat" mood or bloating. Getting it through a prescriber is hard. One endocrinologist willing to prescribe it could find it only as a powder in his prescribing system, which matches the US listings for bulk powder only. Another man's clinic lost its supply, and a third man's compounding pharmacy stopped making it and offered a cypionate-propionate mix instead. A 55-year-old in Germany, injecting 20 mg every morning without a prescription, asked where European pharmacies sell it. [75], [13], [76], [77], [78]
What do the positive reports look like?
Better sex drive is the most common good news, often described as fast. A man in his 30s whose testosterone had been lowered by methadone for chronic pain had lost interest in sex on cypionate, Sustanon and enanthate. On 10 mg of propionate a day, bought online, then 20 mg, he said his libido improved by the next day; injection pain was mild, but hard lumps made fresh sites hard to find. [79]
A man who had managed his own treatment for about 26 months settled on 18 mg every night, injected shallowly into a muscle, and no longer needed an erectile-dysfunction medicine. A test drawn about 13 hours after a dose read 29.7 nmol/L (about 857 ng/dL), with estradiol at 159 pmol/L (about 43 pg/mL); he called both "high normalish" and planned a lower dose. He also takes thyroid hormone. [80]
A 27-year-old whose testosterone was 263 ng/dL (about 9.1 nmol/L) before treatment, possibly after earlier steroid use, described a much higher sex drive on 30 mg every 3 days. He was also exercising more. Daily or every-other-day injections had brought more of the migraines he already had. Another man felt less bloated and hungry than on cypionate or enanthate, without giving doses or tests; replies described both similar and opposite experiences. [81], [82]
Does everyone respond?
No. One man tried 6, 8 and 11 mg a day alongside hCG and DHEA; each felt strong for a few days, then lukewarm, and some injections were followed by anxiety. He went back to cypionate, and replies pointed out that three things had changed at once. Another man, after 5 years of cypionate with brain fog and irritability, switched to 12 mg of propionate a day, matched to his old dose by testosterone content. Two weeks in he felt calmer and clearer but weaker in the gym, with cypionate still clearing from his body. [83], [84]
How often, and at what time, do people inject?
Most describe 10 to 25 mg once a day or every other day, smaller and more often than the labeled 25 mg 2 to 4 times a week; no study has tested these schedules. One man, using an unlicensed product, felt tired and low the day after each 75 mg every-other-day injection and had more energy on 37 mg daily. Either way that is about 260 mg a week, over twice the labels' highest weekly total. Another described better morning drive on 18 mg of subcutaneous propionate every 48 hours, while a reply said 20 mg every 2 days did nothing. [85], [86]
Time of day comes up constantly, mostly because of sleep:
- Night. A man on 15 mg every night later said night injections made his sleep worse. Another, trying 12 to 17.5 mg at different times, woke at 3 a.m. with what he called an adrenaline surge, then had morning headaches; one reply suggested checking his blood pressure. [87], [88]
- Morning. A man on 10 mg each morning felt more energy but lay awake at bedtime, jittery, with occasional headaches. [89]
- Evening. A man taking 120 mg a week as daily evening injections felt his energy fall in the hours before each next dose. [90]
- Prescribed. An endocrinologist switched one man from every-other-day enanthate to daily propionate. After his first late-night dose he woke more easily and had no pain, and he said himself that it might be coincidence. [91]
Does propionate hurt more?
Injection pain is the most common complaint in these threads, and experiences range from none to severe:
- Pain that stopped treatment. A man on pharmacy-compounded 100 mg/mL propionate felt best on it, but his injection sites throbbed within 1 to 2 weeks every time. Replies argued that his half-inch needle was not reaching the muscle. [92]
- Subcutaneous, then into muscle. A first subcutaneous dose hurt too much to finish; daily injections into muscle then left one man's buttocks and thighs so sore that walking hurt, and he went back to longer esters. [93]
- A lump that needed a doctor. After a first thigh injection of an unlicensed product, one man developed a large, hard, red lump. An urgent-care clinician found no staph infection and gave antibiotics to use only if it did not improve. [94]
- Burning or a blend. One man described burning so severe he sometimes could not finish the dose; another had deep, bruise-like thigh pain after each dose of a compounded cypionate-propionate vial (160 and 40 mg/mL), unlike his usual cypionate. [95], [96]
- No pain at all. A man had none two hours after his first 30 mg subcutaneous dose; several replies said they never have pain with propionate, while others said it can appear the next day. [97]
Why do blood results confuse people?
Because the level moves within hours. After 7 days of 15 mg nightly, one man's total testosterone read about 1,550 (units not given), with LH below 1, meaning his own production was already switched off. Another, taking 200 mg a week (twice the Spanish label's top weekly total), had a hematocrit of 53% after two months, drawn an hour before his next injection. [87], [98]
Stopping shows the same speed. A man on 70 mg a week stopped for blood tests needed to move his prescription to his own doctor. Eight days after his last dose his total testosterone was 20 ng/dL (about 0.7 nmol/L), against 334 ng/dL (about 11.6 nmol/L) before he ever started treatment; a second test at his doctor's office read 91 (units not given). He felt very tired but "not horrible." [99] A result taken days after stopping reflects a system that is still switched off, not the level a man had before treatment. [2]
What do people say about blends and switching?
- Hematocrit on a blend. A man on TRT for over 20 years switched to a daily mix of two parts cypionate to one part propionate, injected subcutaneously. He said it brought his hematocrit from about 52 to 54% down to 47 to 49% across four tests. He had also cut his dose by 10 to 20%, and replies argued that hematocrit follows total exposure rather than the ester. [100]
- A prescribed blend. A man whose Sustanon 250 effects faded before each 3-weekly dose was switched by his prescriber to 135 mg of an enanthate-propionate blend (110 mg and 25 mg) every 10 days. He had only just taken the first dose when he updated the thread. [101]
- Switching away. A man in Germany moved from self-managed propionate, 15 mg subcutaneously each day (105 mg a week), to clinician-supervised enanthate twice a week at about 125 mg, which he calculated as the same amount of testosterone. Three weeks later his libido and morning erections were much lower, though his mood was unchanged. He also takes dutasteride and had just tried exemestane, an aromatase inhibitor. [102]
What unwanted effects come up?
- Anxiety. A man in his 20s, who had taken a small dose of anastrozole days before, had repeated bouts of anxiety, tension and dizziness on the second day of daily subcutaneous propionate. [103]
- Breast soreness. A man on 10 mg a day had a sore nipple with a small lump. Anastrozole and tamoxifen did not help; his blood was drawn 10 minutes after waking and after a workout, which replies said can raise prolactin. His doctor later found normal results, but the soreness remained. [104]
How can you judge a propionate story?
Ask: Was it a licensed medicine, a compounded vial or an unlicensed product, and at what strength (mg/mL)? What was the dose in mg, how often, and into muscle or subcutaneously (into the fat)? How many hours after the last injection was blood drawn? What else changed at the same time, such as hCG, an aromatase inhibitor, DHEA, a weight-loss medicine or a longer ester still clearing? What happened a few months later?
These selected discussions show what people experience and the questions research should answer. They are not a survey of all users, a success rate or a substitute for the studies.
How does testosterone propionate compare with other testosterone forms?
These are the forms most often weighed against propionate. Status was checked in September 2026.
| Form | What it is | Route and labeled schedule | What stands out | US status |
|---|---|---|---|---|
| Testosterone propionate (this guide) | Shortest-acting ester in oil | Into a muscle; 25 mg 2–4 times a week (Spain) or 50 mg twice a week (Italy) | One dose lasts about 1 to 2 days; guidelines call the frequency a major limitation | No approved product marketed; compounded only [1], [6], [22] |
| Sustanon 250 | Four esters, including 30 mg of propionate per mL | Into a muscle; usually 250 mg every 3 weeks | Fast start from propionate, long tail from decanoate | Not approved in the US [9], [22] |
| Testosterone cypionate | Longer ester in oil | Into a muscle; 50–400 mg every 2–4 weeks | Levels rise and fall across each 2–4 week interval; label half-life about 8 days | Approved [5] |
| Testosterone enanthate | Longer ester in oil; also the Xyosted autoinjector | Into a muscle, 50–400 mg every 2–4 weeks; Xyosted 75 mg weekly, subcutaneous | Same US vial dosing as cypionate | Approved [105], [74] |
| Testosterone undecanoate injection (Aveed, Nebido) | Long-acting ester | Aveed: 750 mg at start, at 4 weeks, then every 10 weeks | Few injections; boxed warning for oil cough and allergic reactions | Approved (Aveed) [106] |
| Testosterone gel | Daily gel on the skin | For example AndroGel 1.62%: 40.5 mg each morning | No injections; the form used in TRAVERSE | Approved [107], [45] |
No trial ranks these forms on long-term outcomes. The practical differences are how often you dose, how much levels swing and how much hematocrit rises. See cypionate vs enanthate for the most common injectable comparison.
Common questions about testosterone propionate
How often do you inject testosterone propionate?
Every 2 to 4 days on the labels: 2 to 4 times a week in Spain, twice a week in Italy, and every 2 to 3 days in the European urology guideline. One dose keeps testosterone raised for only about 1 to 2 days, which is why it is injected so often. [1], [6], [3], [2] See typical protocols.
How much testosterone propionate is given per week?
The labels give 50 to 100 mg a week (Spain) and 100 mg a week (Italy), split into 2 to 4 injections. The European guideline's text of 50 mg every 2 to 3 days works out to about 117 to 175 mg a week. The prescriber adjusts the dose with blood tests and symptoms. [1], [6], [3] See where protocols differ.
How many units is 50 mg of testosterone propionate?
At 100 mg/mL, 50 mg is 0.5 mL, which is 50 units on a U-100 insulin syringe. At 50 mg/mL (the Italian ampoule), 50 mg is 1 mL. Units on an insulin syringe measure volume, so the answer always depends on the strength printed on your ampoule or vial. [6], [14] Doserly's TRT dose calculator shows each step.
Can testosterone propionate be injected subcutaneously?
The labels say into a muscle only, and no study has measured subcutaneous propionate. The UK evidence for weekly subcutaneous injection comes from enanthate and cypionate, not propionate. Discuss the route with your prescriber before changing it. [1], [21], [31] See into muscle or into the fat.
Why does testosterone propionate hurt?
It has not been studied. Injection pain is the most common complaint in public forums, but no study has compared pain between esters. The Spanish label lists no injection-site reaction, and the Italian label lists a firm swelling at the injection site and boils. Oils, concentrations and additives differ between products, especially compounded and unlicensed ones. [1], [6] See what people report.
Can I switch from cypionate to propionate?
Only with your prescriber. The US cypionate label warns against using the two interchangeably because of their different durations. Propionate also carries more testosterone per milligram (about 84% vs 70%), and the switch changes how often you inject and when blood should be drawn. [5], [4] See mg for mg.
Does testosterone propionate preserve fertility?
There is no evidence that it does in men. It switches off LH while levels are raised, like every form of testosterone, and the only study suggesting it spares fertility was in mice at lower exposure. Guidelines advise against testosterone for men trying to conceive. [2], [40], [41] See fertility and TRT and fertility.
Is testosterone propionate a steroid?
Yes. Testosterone is an anabolic-androgenic steroid hormone, which is why it is a controlled substance. At replacement doses under medical supervision it restores normal levels; bodybuilding use relies on much higher doses with different risks, and the Spanish label warns that misuse can cause serious heart, liver and psychiatric harm and dependence. [53], [1] See TRT vs steroids.
Glossary
Plain explanations of the medical, dosing and research terms used in this guide. Underlined terms in the text link here.
- Adverse event
- A harmful or unwanted medical event reported after someone used a treatment. A report alone does not prove the treatment caused it.
- Ampoule
- A small sealed glass container holding one dose or a set amount of a medicine. Once opened it cannot be resealed, so any leftover is thrown away.
- Animal study
- Research in animals such as rats or mice. It shows what a substance does in a living body, but results in people can differ.
- Aromatase inhibitor
- A medicine, such as anastrozole or exemestane, that blocks the enzyme that turns testosterone into estradiol.
- Azoospermia
- No sperm at all in a semen sample.
- Compounding
- When a pharmacy prepares a medicine from individual ingredients. Compounded testosterone propionate is made from bulk powder and is not FDA-approved.
- Controlled substance
- A medicine whose prescribing and possession are restricted by law because it can be misused. Testosterone is Schedule III in the US, Schedule IV in Canada and Class C in the UK.
- Depot
- A pool of medicine left in the body, such as oil in a muscle, that releases the drug over time. A propionate depot empties within a day or two.
- Ester
- A chemical tail joined to testosterone that makes it dissolve in oil and release more slowly after injection. The body removes the tail to free testosterone. Propionate is the shortest ester used for men; cypionate, enanthate and undecanoate are longer.
- Estradiol
- The main form of estrogen. In men it is made mostly from testosterone, so it rises when testosterone rises.
- FSH (follicle-stimulating hormone)
- A pituitary hormone that acts on the cells supporting sperm production. Testosterone therapy lowers it.
- Gynecomastia
- Growth of breast tissue in men, often tender at first. It is linked to a higher estrogen-to-testosterone balance.
- Half-life
- The time it takes for the level of a substance in the blood to fall by half. For injected testosterone esters it mostly reflects how fast the oil depot releases the drug. Guideline tables give propionate 20 hours.
- Hematocrit
- The share of the blood made up of red blood cells. Testosterone raises it, and most guidelines act when it reaches about 54%. The Spanish propionate label rules out starting above 50%.
- Hypogonadotropic hypogonadism
- Low testosterone because the brain and pituitary send too little LH and FSH to the testicles. It can be present from birth or start later. Also called secondary hypogonadism.
- Hypogonadism
- Low testosterone caused by a problem in the testicles or in the brain and pituitary signals that control them, confirmed with symptoms and repeated morning blood tests.
- Intramuscular (IM)
- Injected into a muscle. The Spanish propionate label specifies deep injection into the buttock muscle, given very slowly.
- LH (luteinizing hormone)
- A pituitary hormone that tells the testicles to make testosterone. Testosterone therapy switches it off; after propionate it stayed off for as long as testosterone stayed raised.
- MACE (major adverse cardiovascular events)
- A combined measure used in heart-safety trials. In TRAVERSE it meant heart attack, stroke or death from heart disease.
- Pharmacokinetics
- How the body absorbs, moves, breaks down and removes a substance.
- Placebo
- A dummy treatment with no active ingredient, used as a comparison in studies.
- Polycythemia (erythrocytosis)
- Too many red blood cells, shown by a high hematocrit. Testosterone therapy is a common cause.
- Pulmonary oil microembolism (POME)
- Tiny droplets of injected oil reaching the lungs, causing a sudden cough or shortness of breath during or soon after an injection. The Spanish propionate label lists it as rare.
- Primary hypogonadism
- Low testosterone because the testicles themselves do not work well, even though the pituitary sends plenty of LH and FSH.
- PSA (prostate-specific antigen)
- A blood test for a protein made by the prostate. It rises slightly on testosterone and is used to decide whether prostate checks are needed.
- Research use only
- A label on products sold for laboratory research. It does not mean a product is approved, tested for human use or legal to sell as a medicine.
- Product information (SmPC)
- The official prescribing document for a licensed medicine in Europe and the UK, called the summary of product characteristics. It plays the role of a US label.
- Subcutaneous (SC)
- Injected into the fatty layer just under the skin. It is not a route on any propionate label, and no study has measured propionate given this way.
- Syringe units
- Markings on an insulin syringe that measure volume. On a U-100 syringe, 100 units equal 1 mL, so 0.5 mL is 50 units.
- Titration
- Adjusting a dose in steps, usually based on blood tests and symptoms.
- Trough level
- The lowest level of a drug in the blood, measured just before the next dose. On propionate the trough comes within a day or two of each injection.
- TRT (testosterone replacement therapy)
- Prescribed testosterone, by injection, gel or other forms, for men with low testosterone. It switches off the brain's LH and FSH signals.
- WADA
- The World Anti-Doping Agency, which publishes the list of substances banned in sport. Testosterone and its esters are banned at all times.
- Weekly total
- All the amounts given in one week, added together. For example, 25 mg four times a week is a 100 mg weekly total.
How this guide was researched
This guide is built from a thorough review of the sources cited throughout it. They include product information from Spain, Italy, the United Kingdom, Australia and the United States, and regulator databases in the United States, Canada, Spain and Italy. They also include clinical guidelines from the United States, Europe and the United Kingdom, published studies of testosterone propionate and large trials of other forms of testosterone. We also reviewed public online forums where people describe their own experiences with testosterone propionate.
The guide cites 107 sources, including 11 product labels, 11 regulator databases and product listings, 11 guidelines and consensus statements, and 19 original studies in people, plus 30 public community threads. Each type of source answers a different question. Labels, guidelines and trials show what was approved and measured. Regulator databases show what is sold where. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labeled by source type.
How this guide was made
Research and drafting were AI-assisted. Every cited source was checked against the original, and the guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.
This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.
Explore the sources
These are the documents cited in this guide. Labels, registers, guidelines, studies and personal accounts answer different questions. A source being listed does not mean every statement on its page is endorsed.
Showing 107 sources
- 01
Testex 25 mg/1 ml solución inyectable (propionato de testosterona): ficha técnica ↗
Product information (Spain)
Full product information reviewed.
Detail: 25 mg in a 1 mL single-use ampoule (equal to 20.9 mg of testosterone); deep intramuscular injection into the buttock 2–4 times a week (50–100 mg a week); contraindicated with hematocrit above 50%, PSA above 4 ng/mL or an enlarged prostate; ethyl oleate and olive oil; no special storage.
- 02
Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men ↗
Human study
Original abstract reviewed.
Result detail: Testosterone stayed above the lower physiological limit for 1 day after 25 mg of propionate, 2 days after 50 mg and 14 days after 250 mg of enanthate; LH was suppressed for the same periods.
- 03
EAU Guidelines on Sexual and Reproductive Health, Chapter 3: Male Hypogonadism ↗
Clinical practice guideline
Original full text reviewed.
Detail: Propionate is a short-term ester usually given as 50 mg every 2–3 days, 'a major limitation for its use'; Table 3.5 lists a 20-hour half-life and 100 mg every 2 days; older injections cause wide fluctuations and possibly polycythaemia; acts on hematocrit above 54%.
- 04
PubChem compound records: testosterone propionate, testosterone, enanthate, cypionate and undecanoate ↗
Chemistry database
Structured records reviewed.
Detail: Testosterone propionate C22H32O3, molecular weight 344.5; testosterone 288.4. Doserly's arithmetic: testosterone makes up about 84% of propionate, 72% of enanthate, 70% of cypionate and 63% of undecanoate by weight.
- 05
DEPO-Testosterone (testosterone cypionate) injection, USP CIII ↗
Product label (US)
Full label reviewed.
Detail: Cypionate label; warns that cypionate should not be used interchangeably with testosterone propionate because of differences in duration of action; half-life about 8 days.
- 06
Testovis 100 mg/2 ml soluzione iniettabile per uso intramuscolare: riassunto delle caratteristiche del prodotto ↗
Product information (Italy)
Full product information reviewed.
Detail: Gives 50 mg (1 mL, half an ampoule) intramuscularly twice a week for at least 2 months for adult hypogenitalism (eunuchoidism), discarding the rest; the male hypogonadism indication itself has no separate dose; sesame oil; protect from light. Also lists older uses this guide does not present, and claims a 4-week effect that human studies contradict.
- 07
CIMA register: Testex 25 mg/1 ml solución inyectable (registration 19207) ↗
Regulator database (Spain)
Structured register records reviewed.
Detail: Authorised, flagged as marketed and prescription-only; first authorised June 1953. Testex Prolongatum is cypionate, not propionate. A register flag shows marketing status, not stock on a given day.
- 08
AIFA medicines database: Testovis 100 mg/2 ml (package 003559059) ↗
Regulator database (Italy)
Structured register records reviewed.
Detail: Authorised, flagged as marketed, fully reimbursed (class A) on a restricted prescription, intramuscular; flagged as a doping substance banned in and out of competition. A register flag shows marketing status, not stock.
- 09
Sustanon 250, 250 mg/ml solution for injection: summary of product characteristics ↗
Product information (UK)
Full product information reviewed.
Detail: Each 1 mL contains propionate 30 mg, phenylpropionate 60 mg, isocaproate 60 mg and decanoate 100 mg; usually 1 mL every 3 weeks; peak about 70 nmol/L at 24–48 hours, back to the lower normal limit in about 21 days.
- 10
electronic medicines compendium: medicines containing testosterone propionate ↗
Product information listings (UK)
Current listings reviewed.
Detail: One product, Sustanon 250; no propionate-only product. emc is not the full UK register.
- 11
Sustanon 250 (mixed testosterone esters): Australian product information ↗
Product information (Australia)
Full product information reviewed.
Detail: Same four-ester formula; usually one 1 mL injection every three weeks.
- 12
AIFA medicines database search: medicines containing testosterone propionate ↗
Regulator database (Italy)
Structured register records reviewed.
Detail: Two products contain propionate: Testovis (propionate only) and Sustanon (four esters).
- 13
National Drug Code Directory: listings for testosterone propionate (openFDA) ↗
FDA product listing
Structured data reviewed.
Detail: All 18 current listings are Schedule III bulk powder, several marked for human prescription compounding; no finished medicine is listed.
- 14
Drug Product Database: Testosterone Propionate Injection USP 100 mg/mL (StériMax, DIN 01977571) ↗
Regulator database (Canada)
Structured database records reviewed.
Detail: Intramuscular, 100 mg/mL; Schedule IV controlled drug; dormant (not marketed) since August 3, 2017.
- 15
ENDOCRINE HISTORY: The history of discovery, synthesis and development of testosterone for clinical use ↗
Historical review
Original abstract reviewed.
Detail: Testosterone was isolated and synthesized in 1935.
- 16
New Zealand Gazette No. 67: list of therapeutic preparations ↗
Official government record
Original document reviewed.
Detail: Lists 'Testoviron' (testosterone propionate) made by Schering-Kahlbaum, Berlin.
- 17
Testosterone deficiency: a historical perspective ↗
Historical review
Original full text reviewed.
Detail: Testosterone was used first as pellets, then as injectable propionate with a short half-life; enanthate took over from the mid-1950s.
- 18
The effects of clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy ↗
Human study
Original abstract reviewed.
Result detail: Describes a 'testosterone propionate depot' given as 250 mg every 21 days, showing how older papers used the name for longer-acting products.
- 19
Warning letter MARCS-CMS 610751 to a 503B outsourcing facility ↗
Regulator enforcement record (US)
Original page reviewed.
Detail: Records a compounded 'Testosterone cypionate/ Testosterone propionate 200mg/10mg Injection'; the firm had no FDA-approved applications for the products it compounded.
- 20
Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024) ↗
International consensus recommendations
Original full text reviewed.
Detail: Mid-normal target; short-acting injections monitored at mid-cycle.
- 21
Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism ↗
Clinical practice guideline
Original full text reviewed.
Detail: Enanthate or cypionate 50–100 mg weekly, intramuscular or subcutaneous; short-acting injections, including Sustanon, adjusted by trough level; adjust treatment if hematocrit is above 50%.
- 22
Drugs@FDA: applications with the active ingredient testosterone propionate (openFDA) ↗
FDA product listing
Structured data reviewed.
Detail: All 9 applications listed (25, 50 and 100 mg/mL injections) are marked discontinued.
- 23
Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE) ↗
Clinical practice guideline
Original full text reviewed.
Detail: Table 2 lists Testovis (propionate) with a 20-hour half-life at 100 mg every 2 days and calls it very short-acting; short-acting injections give wider fluctuations; prefers gels and long-acting injections.
- 24
DailyMed label search: testosterone propionate ↗
Label database (US)
Search results reviewed.
Detail: No human testosterone propionate label; the only result is a veterinary cattle implant.
- 25
Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism ↗
Human trial (randomized; TRAVERSE substudy)
Original abstract reviewed.
Result detail: In 1,161 men with low libido, sexual activity rose about 0.5 acts a day more than placebo, lasting to 24 months; erections did not improve.
- 26
Effects of Testosterone Treatment in Older Men ↗
Human trial (randomized)
Original full text reviewed.
Result detail: 790 men aged 65 or older; a year of gel improved sexual function a little, not energy or walking in the physical function trial.
- 27
Pharmacokinetic properties of testosterone propionate in normal men ↗
Human study
Original abstract reviewed.
Result detail: After a 25 mg intramuscular dose of tracer-tagged (deuterium-labelled) propionate, the ester stayed at 2–4 ng/mL from 3 to 36 hours, and testosterone from the dose stayed above the physiological level for 48 hours.
- 28
Onset of effects of testosterone treatment and time span until maximum effects are achieved ↗
Review
Original abstract reviewed.
Detail: Sexual interest from about 3 weeks; erections up to 6 months; body composition over 12–16 weeks.
- 29
European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males ↗
Clinical practice guideline
Original full text reviewed.
Detail: Older injections such as propionate and enanthate may cause wide fluctuations, reported as unpleasant mood and energy swings, and are possibly associated with more polycythaemia.
- 30
The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice ↗
Clinical practice guideline
Original full text reviewed.
Detail: Lists testosterone propionate only as one of the four esters in Sustanon 250, usually given every 3 weeks.
- 31
ClinicalTrials.gov search: intervention 'testosterone propionate' ↗
Trial registry search
Search results reviewed.
Detail: No record among the results named testosterone propionate as an intervention for low testosterone.
- 32
Long vs Short Acting Testosterone Treatments: A Look at the Risks ↗
Review
Original full text reviewed.
Detail: Classes all intramuscular injections as long-acting and nasal, oral and skin products as short-acting; does not discuss propionate.
- 33
Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis ↗
Human study (pooled analysis)
Original abstract reviewed.
Result detail: 1,549 healthy men; sperm back to 20 million/mL in 67% by 6 months, 90% by 12, 96% by 16 and 100% by 24 months.
- 34
Endogenous and exogenous testosterone levels after administration of deuterium-labelled testosterone propionate in hypogonadotropic hypogonadism ↗
Human study
Original abstract reviewed.
Result detail: In 3 men with hypogonadotropic hypogonadism, testosterone from one tracer-tagged dose (amount not given in the abstract) stayed above 4 ng/mL (400 ng/dL) for 48 hours.
- 35
Effects of depot testosterone administration on serum levels of testosterone, FSH, LH and prolactin ↗
Human study
Original abstract reviewed.
Result detail: In 28 older men, 100 mg of a product labelled testosterone propionate kept testosterone raised through day 7 (samples on days 2, 4, 7 and 15); formulation not described in the abstract.
- 36
Short-term parenteral and peroral testosterone administration in men with alcoholic cirrhosis ↗
Human study
Original abstract reviewed.
Result detail: 24 men with alcoholic cirrhosis across three regimens (propionate group size not given); with propionate every other day, serum testosterone became fairly constant after 4 days.
- 37
Effects of short-term testosterone replacement on areal bone mineral density and bone turnover in young hypogonadal males ↗
Human study
Original abstract reviewed.
Result detail: Young men with hypogonadism were treated with a mixed enanthate and propionate product, 250 mg every 2–3 weeks.
- 38
USP monograph: Testosterone Propionate Injection ↗
Pharmacy standard (US)
Public preview reviewed.
Detail: Defines the injection as a sterile solution of testosterone propionate in a suitable vegetable oil.
- 39
Delayed oleoma formation with injection of oil-suspended testosterone: A case report and review of pathogenesis ↗
Case report
Original abstract reviewed.
Result detail: Oil-filled granulomas (oleomas) appeared years after unsupervised injections of testosterone in oil; the ester was not identified.
- 40
Short-acting testosterone appears to have lesser effect on male reproductive potential compared to long-acting testosterone in mice ↗
Animal study
Original full text reviewed.
Result detail: Normal mice given propionate into the abdomen three times a week kept LH and fertility better than mice given pellets, but reached lower testosterone (122 vs 286 ng/dL); small groups.
- 41
Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline (2020; amended 2024) ↗
Clinical practice guideline
Original full text reviewed.
Detail: Clinicians should not prescribe testosterone to men interested in current or future fertility.
- 42
Evaluation and Management of Testosterone Deficiency: AUA Guideline ↗
Clinical practice guideline
Original full text reviewed.
Detail: Measure estradiol mainly with breast symptoms; intervene at hematocrit 54% or higher; prefer commercially made testosterone over compounded products when possible.
- 43
Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100 mg IM weekly or 200 mg IM biweekly ↗
Human study (observational)
Original abstract reviewed.
Result detail: Hematocrit above 54% in 1 of 102 on weekly 100 mg vs 4 of 51 on 200 mg every 2 weeks; ester not stated in the abstract.
- 44
Effect of testosterone preparations on the function of the hypothalamic pituitary axis in Klinefelter's syndrome ↗
Human study
Original abstract (English) reviewed.
Result detail: Compared three injectable preparations (propionate 25 mg three times a week, a 100 mg product every 10 days and enanthate 200 mg every 20 days) in 6 healthy men and 17 men with Klinefelter syndrome; LH took about a month and FSH 3 to 6 months to normalise, with results not reported per preparation.
- 45
Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE) ↗
Human trial (randomized)
Original abstract reviewed.
Result detail: 5,204 men on daily gel or placebo; heart attack, stroke or heart death 7.0% vs 7.3% (hazard ratio 0.96); mean treatment 21.7 months.
- 46
KYZATREX (testosterone undecanoate) capsules ↗
Product label (US)
Full label reviewed.
Detail: Carries the TRAVERSE class text: atrial fibrillation 3.5% vs 2.4%, acute kidney injury 2.3% vs 1.5%, venous clots 1.7% vs 1.2%; about 61% stopped their study gel early.
- 47
Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial ↗
Human trial (randomized; TRAVERSE substudy)
Original abstract reviewed.
Result detail: No significant reduction in progression from prediabetes to diabetes (overall P=0.49).
- 48
Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy ↗
Human trial (randomized; TRAVERSE substudy)
Original abstract reviewed.
Result detail: No improvement in late-life persistent depressive disorder (49 men qualified); small improvements in mood and energy.
- 49
Pharmacokinetic studies of testosterone propionate using gas chromatography/mass spectrometry/selected ion monitoring ↗
Human study (methods)
Original abstract reviewed.
Result detail: Injected propionate was readily transferred from the injection site into the circulation; same research group and data as Fujioka 1986.
- 50
Testosterone Treatment and Fractures in Men with Hypogonadism ↗
Human trial (randomized; TRAVERSE substudy)
Original abstract reviewed.
Result detail: Clinical fractures 91 of 2,601 (3.50%) vs 64 of 2,603 (2.46%).
- 51
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial ↗
Human trial (randomized; TRAVERSE substudy)
Original full text reviewed.
Result detail: High-grade prostate cancer 5 of 2,596 (0.19%) vs 3 of 2,602 (0.12%); not significant; men with PSA above 3.0 ng/mL were excluded.
- 52
Withdrawal of approval of 42 new drug applications, including NDA 7-029 Perandren Propionate Injection ↗
Regulatory notice (US)
Original document reviewed.
Detail: Ciba-Geigy told FDA that Perandren Propionate Injection was no longer marketed; the withdrawal took effect on November 10, 1986.
- 53
21 CFR 1308.13 Schedule III (anabolic steroids) ↗
Regulation (US)
Original page reviewed.
Detail: Anabolic steroids, including testosterone and its esters, are Schedule III.
- 54
21 U.S.C. 802(41): definition of anabolic steroid ↗
Legislation (US)
Original text reviewed.
Detail: Testosterone is named in the statutory definition of anabolic steroid.
- 55
Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act ↗
Regulator guidance (US)
Original page reviewed.
Detail: Pharmacies compounding under section 503A may use bulk substances that meet an applicable USP monograph, are components of FDA-approved drugs, or appear on FDA's 503A list.
- 56
USP monograph: Testosterone Propionate ↗
Pharmacy standard (US)
Public preview reviewed.
Detail: Quality standard for the drug substance (C22H32O3, molecular weight 344.49).
- 57
Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the FD&C Act (categories) ↗
Regulator list (US)
Original document reviewed.
Detail: Testosterone propionate sits in Category 1, bulk substances under evaluation for outsourcing facilities.
- 58
FDA issues class-wide labeling changes for testosterone products ↗
Regulator notice (US)
Original page reviewed.
Detail: Adds TRAVERSE results and blood-pressure warnings to testosterone labels, removes boxed-warning language on heart risk and recounts the 2015 age-related limitation.
- 59
HHS Announces Requested Updates to Testosterone Therapy Product Labels ↗
Regulator notice (US)
Original page reviewed.
Detail: FDA is requesting removal of the age-related limitation, a contraindication only in metastatic prostate cancer, and a revised prostate-enlargement warning; requested, not yet in labels (checked September 2026).
- 60
Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications ↗
Regulation (US)
Original page reviewed.
Detail: Flexibilities run from January 1 to December 31, 2026.
- 61
OIRA review record: Special Registrations for Telemedicine (RIN 1117-AB40), final rule stage ↗
Regulatory record (US)
Original page reviewed.
Detail: The DEA special-registration final rule is under review, not published (checked September 2026).
- 62
Controlled Drugs and Substances Act (S.C. 1996, c. 19), Schedule IV ↗
Legislation (Canada)
Original page reviewed.
Detail: Anabolic steroids, including testosterone, are Schedule IV.
- 63
Drug Product Database: other testosterone propionate products ↗
Regulator database (Canada)
Structured database records reviewed.
Detail: Taro's 100 mg/mL product was cancelled on August 21, 2001 and Malogen in Oil on April 14, 1999; the remaining listings are veterinary.
- 64
Misuse of Drugs Act 1971, Schedule 2 Part III (Class C drugs) ↗
Legislation (UK)
Original page reviewed.
Detail: Testosterone is a Class C controlled drug.
- 65
Therapeutic Goods (Poisons Standard, June 2026) Instrument 2026 ↗
Legislation (Australia)
Original page reviewed.
Detail: Testosterone is Schedule 4 (prescription only), with Appendix D controls on possession.
- 66
Testosterone medicines with current Australian product information (TGA) ↗
Product information listings (Australia)
Current product information documents reviewed.
Detail: Current documents cover undecanoate injections, Primoteston Depot (enanthate), Sustanon 250, Testogel, Testavan and AndroForte 5; propionate appears only inside Sustanon 250.
- 67
World Anti-Doping Code International Standard: Prohibited List 2026 ↗
Anti-doping rule
Original document reviewed.
Detail: Testosterone and its esters are S1 anabolic agents, prohibited at all times.
- 68
World Anti-Doping Code International Standard: Prohibited List 2027 ↗
Anti-doping rule
Original document reviewed.
Detail: Keeps testosterone prohibited at all times.
- 69
TUE Physician Guidelines: Male Hypogonadism, Version 9 ↗
Anti-doping guidance
Original document reviewed.
Detail: Exemptions only for organic hypogonadism, not functional low testosterone from aging, obesity or earlier steroid use.
- 70
TESTOPEL (testosterone pellets) for subcutaneous implantation ↗
Product label (US)
Full label reviewed.
Detail: Sets the pellet dose in propionate terms: two 75 mg pellets for each 25 mg of testosterone propionate needed weekly.
- 71
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline ↗
Clinical practice guideline
Original full text reviewed.
Detail: Hematocrit at baseline, 3–6 months and yearly, stopping above 54% until it falls; urology referral for a PSA rise above 1.4 ng/mL in 12 months or above 4.0 ng/mL.
- 72
Evaluation for and Management of Males with Low Testosterone: Recommendations for Use ↗
Health-system clinical recommendations
Original full text reviewed.
Detail: Adjust the dose if hematocrit is above 51%; stop if above 54%.
- 73
Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A ↗
Clinical practice guideline
Original full text reviewed.
Detail: Persistent hematocrit of 55% or more may be managed by dose reduction, a break, a formulation change or blood donation.
- 74
XYOSTED (testosterone enanthate) injection, for subcutaneous use ↗
Product label (US)
Full label reviewed.
Detail: 75 mg once weekly by subcutaneous autoinjector; like other US labels, gives no numeric hematocrit stopping threshold.
- 75
My Dr asked about Test P availability. Help? ↗
Community account
Public thread reviewed: opening post and 4 comments.
Detail: An endocrinologist willing to prescribe propionate could find it only as a powder in his prescribing system.
- 76
What tele clinics are prescribing test prop? ↗
Community account
Public thread reviewed: opening post and 1 comments.
Detail: A man reported that his local clinic could no longer obtain propionate.
- 77
Test propionate source help ↗
Community account
Public thread reviewed: opening post and 2 comments.
Detail: A man treated through a clinic for 2 years reported that his compounding pharmacy stopped making propionate and offered a cypionate-propionate mix instead.
- 78
Where in Europe can I find testosterone propionate in pharmacies? ↗
Community account
Public thread reviewed: opening post and 11 comments.
Detail: A man in his 50s in Germany, injecting 20 mg each morning without a prescription, asked where European pharmacies sell propionate.
- 79
Test P has become the only Testosterone that works for me. What happened? ↗
Community account
Public thread reviewed: opening post and 22 comments.
Detail: A man in his 30s whose testosterone fell on methadone for chronic pain reported that daily propionate, bought online, improved his libido within days, with mild pain and hard lumps at injection sites.
- 80
My experience with 18mg of test prop daily. ↗
Community account
Public thread reviewed: opening post and 84 comments.
Detail: A man managing his own treatment for about 26 months described nightly 18 mg shallow intramuscular propionate, better sexual function and a family-doctor test of 29.7 nmol/L the next morning.
- 81
TRT Prop 60mg crazy libido? ↗
Community account
Public thread reviewed: opening post and 29 comments.
Detail: A man in his 20s with low testosterone, possibly after earlier steroid use, reported higher libido on 30 mg every 3 days and more migraines on daily or every-other-day injections.
- 82
Test p feels so different than other tests ↗
Community account
Public thread reviewed: opening post and 51 comments.
Detail: A man reported less bloating and hunger and more energy on propionate than on cypionate or enanthate, without doses or tests; replies were mixed.
- 83
Issues with test Prop ↗
Community account
Public thread reviewed: opening post and 6 comments.
Detail: A man tried 6 to 11 mg of propionate daily alongside hCG and DHEA, felt strong effects for a few days, then inconsistent ones, and returned to cypionate.
- 84
Switched from Cyp to Prop, feeling weaker? ↗
Community account
Public thread reviewed: opening post and 7 comments.
Detail: After 5 years of cypionate, a man switched to 12 mg of propionate daily and after 2 weeks felt calmer and clearer but weaker in training.
- 85
Test prop short half-life ↗
Community account
Public thread reviewed: opening post and 10 comments.
Detail: A man using an unlicensed product felt tired the day after 75 mg every-other-day injections and reported more energy on 37 mg daily.
- 86
test prop 18 mg eod 3:30 pm ↗
Community account
Public thread reviewed: opening post and 6 comments.
Detail: A man described 18 mg of subcutaneous propionate every 48 hours in the afternoon and better morning drive; one reply reported no benefit at a similar dose.
- 87
Test prop TRT how long until natural test is off. ↗
Community account
Public thread reviewed: opening post and 9 comments.
Detail: A man starting 15 mg nightly had total testosterone near 1,550 (units not given) and LH below 1 after 7 days, and later said night injections worsened his sleep.
- 88
Waking up with headaches Test prop. ↗
Community account
Public thread reviewed: opening post and 7 comments.
Detail: A man trying 12 to 17.5 mg daily at different times reported waking at 3 a.m. with an adrenaline feeling and later morning headaches.
- 89
Is pinning test propionate better before sleep or in the morning ↗
Community account
Public thread reviewed: opening post and 10 comments.
Detail: A man injecting 10 mg each morning felt more energy but also wakefulness at bedtime, jitteriness and occasional headaches.
- 90
When do you pin ur test p ↗
Community account
Public thread reviewed: opening post and 6 comments.
Detail: A man taking 120 mg a week as daily evening injections felt his energy fall in the hours before each next dose.
- 91
Test prop morning or night ↗
Community account
Public thread reviewed: opening post and 18 comments.
Detail: An endocrinologist switched a man from every-other-day enanthate to daily propionate; after his first late-night dose he woke more easily and had no pain.
- 92
Test Prop - diluting with sterile carrier oil ↗
Community account
Public thread reviewed: opening post and 15 comments.
Detail: A man using pharmacy-compounded 100 mg/mL propionate felt best on it but could not keep going beyond 1 to 2 weeks because of injection-site pain.
- 93
Extreme PIP Subq Test Prop ↗
Community account
Public thread reviewed: opening post and 22 comments.
Detail: A man had severe pain from a first subcutaneous propionate dose, then painful glutes and thighs on daily intramuscular injections, and planned to return to longer esters.
- 94
Testosterone Propionate PIP/swelling ↗
Community account
Public thread reviewed: opening post and 99 comments.
Detail: A man developed pain, redness and a hard lump after a first thigh injection of an unlicensed propionate; urgent care found no staph infection.
- 95
TEST PROP PAIN DURING SHOT ↗
Community account
Public thread reviewed: opening post and 8 comments.
Detail: A man injecting every other day described burning pain so severe that he sometimes could not finish the injection.
- 96
Test vial Cypionate 160mg/mL 40mg/mL Propionate…PIP ↗
Community account
Public thread reviewed: opening post and 10 comments.
Detail: A man sent a compounded cypionate-propionate vial (160 and 40 mg/mL) reported deep, bruise-like thigh pain the day after each of two injections.
- 97
Test P no PIP at all? ↗
Community account
Public thread reviewed: opening post and 15 comments.
Detail: A man had no pain two hours after a first 30 mg subcutaneous dose; several replies reported no pain with propionate, others that pain can appear later.
- 98
On 200Mg Test P weekly and this is my bloods taken 1 hour before I’m due to take next shot ↗
Community account
Public thread reviewed: opening post and 6 comments.
Detail: A man taking 200 mg of propionate a week reported a hematocrit of 53% after two months, drawn an hour before his next injection.
- 99
Really crashed my Total T number ↗
Community account
Public thread reviewed: opening post and 19 comments.
Detail: A man on 70 mg of propionate a week reported total testosterone of 20 ng/dL 8 days after stopping, against 334 ng/dL before he first started treatment.
- 100
Simple way to moderately reduce HCT: CYP+Prop blend daily shots. ↗
Community account
Public thread reviewed: opening post and 5 comments.
Detail: A man on TRT for over 20 years reported hematocrit falling from about 52 to 54% to 47 to 49% after switching to a daily cypionate-propionate mix and lowering his dose.
- 101
Sustanon 250 prescribed every 3 weeks for Low T ↗
Community account
Public thread reviewed: opening post and 3 comments.
Detail: A man whose Sustanon 250 effects faded before each 3-weekly dose was switched by his prescriber to an enanthate-propionate blend every 10 days.
- 102
Libidoprobleme nach switch von Test P auf Test E ↗
Community account
Public thread reviewed: opening post and 18 comments.
Detail: A man in Germany moved from self-managed daily propionate to clinician-supervised twice-weekly enanthate and reported lower libido and morning erections 3 weeks later.
- 103
Started test propionate every day subq 20 mg and massive anxiety on the second day for now reason . ↗
Community account
Public thread reviewed: opening post and 12 comments.
Detail: A man in his 20s who started daily subcutaneous propionate reported sudden anxiety, tension and dizziness on the second day.
- 104
Blood test just arrived, I'm on 70mg test p, pinning every day 10mg.Can somebody help me to get these markers to normal? Thanks ↗
Community account
Public thread reviewed: opening post and 14 comments.
Detail: A man on 10 mg of propionate daily reported a sore nipple with a small lump that persisted after other medicines and a doctor's normal results.
- 105
Testosterone enanthate injection, USP (Hikma) ↗
Product label (US)
Full label reviewed.
Detail: 50 to 400 mg every 2 to 4 weeks in sesame oil; testosterone's own half-life reported as 10 to 100 minutes.
- 106
AVEED (testosterone undecanoate) injection ↗
Product label (US)
Full label reviewed.
Detail: 750 mg at start, at 4 weeks, then every 10 weeks; boxed warning for oil microembolism and anaphylaxis with 30 minutes' observation.
- 107
ANDROGEL (testosterone gel) 1.62% ↗
Product label (US)
Full label reviewed.
Detail: Starts at 40.5 mg each morning; boxed warning on secondary exposure of children.
No matching sources
Try a different term or show the full list.